Inventor · disambiguated record
Luigi Piero Stasi
Also filed as: STASI LUIGI · STASI LUIGI P · STASI LUIGI PIERO
23 granted patents·13 pending applications·33 citations·filing 2003–2025
92Inventor score
Files withNUEVOLUTION AS9GLAXO GROUP LTD7GLAXOSMITHKLINE IP DEV LTD4RYVU THERAPEUTICS S A4BORRIELLO MANUELA3
Top patents by PatentIndex Score
36 records- 0188US10689383B2Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseasesNUEVOLUTION AS·Filed 2015·Granted Jun 23, 2020·6 cites·59 claims
- 0284US10683293B2Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseasesNUEVOLUTION AS·Filed 2015·Granted Jun 16, 2020·3 cites·42 claims
- 0383US7459456B2Quinoline and quinazoline derivatives having affinity for 5HT1-type receptorsGLAXO GROUP LTD·Filed 2007·Granted Dec 2, 2008·7 cites·12 claims
- 0481US11254681B2Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseasesNUEVOLUTION AS·Filed 2020·Granted Feb 22, 2022·1 cites·54 claims
- 0577US12344606B2Next-generation modulators of stimulator of interferon genes (STING)RYVU THERAPEUTICS S A·Filed 2020·Granted Jul 1, 2025·2 cites·11 claims
- 0677US9815841B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Nov 14, 2017·2 cites·13 claims
- 0775US12441704B2Compounds active towards nuclear receptorsNUEVOLUTION AS·Filed 2023·Granted Oct 14, 2025·0 cites·18 claims
- 0872US10618901B2LRRK2 inhibitors for the treatment of Parkinson's diseaseGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Apr 14, 2020·1 cites·21 claims
- 0972US7592346B2Quinoline and quinazoline derivatives having affinity for 5HT1-type receptorsGLAXO GROUP LTD·Filed 2008·Granted Sep 22, 2009·1 cites·25 claims
- 1070US8828987B2Pyridine amide derivatives as EP4 receptor antagonistsBORRIELLO MANUELA·Filed 2010·Granted Sep 9, 2014·4 cites·27 claims
- 1169US8859608B2Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addictionSTASI LUIGI PIERO·Filed 2010·Granted Oct 14, 2014·3 cites·17 claims
- 1267US10975081B2Substituted fused pyrazole compounds and their use as LRRK2 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Apr 13, 2021·1 cites·18 claims
- 1367US10087186B2Compounds as LRRK2 kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Oct 2, 2018·1 cites·15 claims
- 1466US11685727B2Compounds active towards nuclear receptorsNUEVOLUTION AS·Filed 2020·Granted Jun 27, 2023·0 cites·16 claims
- 1566US9120824B2Cyclic amine derivatives as EP4 receptor agonistsBORRIELLO MANUELA·Filed 2011·Granted Sep 1, 2015·1 cites·11 claims
- 1666US7732600B2Quinoline and quinazoline derivatives having affinity for 5HT1-type receptorsGLAXO GROUP LTD·Filed 2009·Granted Jun 8, 2010·0 cites·4 claims
- 1762US2025134890A1Antimalarial hexahydropyrimidine analoguesUCB Biopharma SRL·Filed 2023·Application pending·0 cites
- 1861US2025382308A1Compounds active towards bromodomainsNUEVOLUTION AS·Filed 2023·Application pending·0 cites
- 1957US2025313561A1Next-generation modulators of stimulator of interferon genes (sting)RYVU THERAPEUTICS S A·Filed 2025·Application pending·0 cites
- 2055US2024294534A1Imidazotriazine derivatives as il-17 modulatorsUCB Biopharma SRL·Filed 2022·Application pending·0 cites
- 2154US11780843B2Compounds active towards nuclear receptorsNUEVOLUTION AS·Filed 2021·Granted Oct 10, 2023·0 cites·20 claims
- 2254US11613532B2Compounds active towards nuclear receptorsNUEVOLUTION AS·Filed 2021·Granted Mar 28, 2023·0 cites·21 claims
- 2354US2009076274A1Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disordersGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 2452US11447479B2Compounds active towards nuclear receptorsNUEVOLUTION AS·Filed 2020·Granted Sep 20, 2022·0 cites·21 claims
- 2551US2011053979A1Pyridine derivatives used to treat orexin related disordersALVARO GIUSEPPE·Filed 2009·Application pending·0 cites
- 2651US2010204273A1Quinoline and Quinazoline Derivatives Having Affinity for 5HT1-Type ReceptorsGLAXO GROUP LTD·Filed 2010·Application pending·0 cites
- 2747US9498478B2Spiro aminic compounds with NK1 antagonist activityRottapharm Biotech Srl·Filed 2015·Granted Nov 22, 2016·0 cites·6 claims
- 2845US2010190764A1Novel compoundsGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 2944US9174977B22-azabicyclo[4.1.0]heptane derivatives as orexin receptor antagonists for the treatment of certain disordersRottapharm Biotech Srl·Filed 2013·Granted Nov 3, 2015·0 cites·7 claims
- 3044US2006264429A1Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disordersBERTANI BARBARA·Filed 2003·Application pending·0 cites
- 3141US2013310400A1Spiro aminic compounds with nk1 antagonist activitySTASI LUIGI PIERO·Filed 2012·Application pending·0 cites
- 3239US2008090822A1Piperazine Derivatives As Glyt 1 InhibitorsGLAXO GROUP LTD·Filed 2006·Application pending·0 cites
- 3338US2023076506A1Heterocyclic compounds as modulators of stimulator of interferon genes (sting)RYVU THERAPEUTICS S A·Filed 2020·Application pending·0 cites
- 3438US2023055741A1Functionalized heterocyclic compounds as modulators of stimulator of interferon genes (sting)RYVU THERAPEUTICS S A·Filed 2020·Application pending·0 cites
- 3537US9062033B2Chemical compoundsRottapharm Biotech Srl·Filed 2012·Granted Jun 23, 2015·0 cites·7 claims
- 3633US9181279B2Cyclic amine derivatives as EP4 receptor antagonistsBORRIELLO MANUELA·Filed 2011·Granted Nov 10, 2015·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when Luigi Piero Stasi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →